Geneva Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Geneva Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,230	Closed	-$200K	–	747
2015 Q4	$200K	Buy	+9,230	New	+$180K	﹤0.01%	569
2015 Q3	–	Sell	-8,150	Closed	-$283K	–	702
2015 Q2	$283K	Hold	8,150	–	–	0.01%	537
2015 Q1	$212K	Sell	8,150 -3,000	-27%	-$55K	﹤0.01%	586
2014 Q4	$144K	Hold	11,150	–	–	﹤0.01%	616
2014 Q3	$137K	Hold	11,150	–	–	﹤0.01%	604
2014 Q2	$176K	Hold	11,150	–	–	﹤0.01%	606
2014 Q1	$169K	Buy	11,150 +1,150	+12%	+$13K	﹤0.01%	579
2013 Q4	$76K	Hold	10,000	–	–	﹤0.01%	501
2013 Q3	$34K	Buy	+10,000	New	+$26.4K	﹤0.01%	488

Other funds holding HZNP

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return